Gert van der Hoek
In Memoriam - Editor, Senior Moderator
Breakthrough drug 'can kill MRSA'
06 NOVEMBER 2014
Scientists believe they have found an alternative to antibiotics which could be used to combat superbugs such as MRSA.
A small test study suggested the new drug, an enzyme that solely targets the bacteria in MRSA, was effective against the infection with scientists claiming the likelihood of the bug becoming resistant was "very limited".
Dutch biotech firm Micreos presented the findings at the EuroSciCon meeting, called Antibiotics Alternatives for the New Millenium, in London yesterday.
The new drug, Staphefekt, is based on naturally occurring enzymes called endolysins, which are found in viruses and kill bacteria in a different way to antibiotics.
In one observational study, Staphefekt killed MRSA in five out of six people suffering skin conditions such as dermatitis and eczema.
The firm is to conduct clinical trials of Staphefekt and is looking to expand them internationally.
Belfast Telegraph
06 NOVEMBER 2014
Scientists believe they have found an alternative to antibiotics which could be used to combat superbugs such as MRSA.
A small test study suggested the new drug, an enzyme that solely targets the bacteria in MRSA, was effective against the infection with scientists claiming the likelihood of the bug becoming resistant was "very limited".
Dutch biotech firm Micreos presented the findings at the EuroSciCon meeting, called Antibiotics Alternatives for the New Millenium, in London yesterday.
The new drug, Staphefekt, is based on naturally occurring enzymes called endolysins, which are found in viruses and kill bacteria in a different way to antibiotics.
In one observational study, Staphefekt killed MRSA in five out of six people suffering skin conditions such as dermatitis and eczema.
The firm is to conduct clinical trials of Staphefekt and is looking to expand them internationally.
Belfast Telegraph